Nycomed, a pharmaceutical company based in Zurich, Switzerland, was acquired by Takeda Pharmaceutical Co. in 2011. Takeda’s motive for acquiring Nycomed was multifold. Some of Nycomed’s products and pipeline were within segments hitherto not covered by Takeda, and would therefore constitute an enrichment of the Takeda product portfolio. Nycomed was well established in regions were Takeda’s presence was weak, especially Europe including Russia. Furthermore, the acquisition of Nycomed would mean a boost to Takeda’s evolution toward attaining an internationalized corporate culture.

History of Nycomed

Nycomed was founded by the pharmacist Morten Nyegaard in Norway in 1874 in order to sell imported drugs. The company was named Nyegaard & Co. (NYCO) during 1890 to 1986. Some main products were vitamins and a generic version of aspirin, Globoid, from ...

  • Loading...
locked icon

Sign in to access this content

Get a 30 day FREE TRIAL

  • Watch videos from a variety of sources bringing classroom topics to life
  • Read modern, diverse business cases
  • Explore hundreds of books and reference titles